Issue dtd. November 2006
INSIDE
COVER STORY
MARKET
RENDEZVOUS
IN NEWS
IN CONVERSATION
ANALYSIS
TECHNOLOGY
ACCREDITATION
CONFERENCE WATCH
DIAGNOSTIC
EHM PEOPLE
BOOKMARK
FEEDBACK
PRODUCTS

ARCHIVES
SUBSCRIBE
CUSTOMER SERVICE
CONTACT US
ADVERTISE
ABOUT US


 Network Sites

  Express Computer

  IT People
  Network Magazine
  Business Traveller
  Express Hospitality
  Express TravelWorld
  Express Pharma
  Express Textile
 Group Sites
  ExpressIndia
  Indian Express
  Financial Express

Untitled Document
 

 

-
Home > In News > Story

Seegene Introduces New Dengue Virus Molecular Diagnostics

EHM News Bureau

A new multiplex PCR system has ushered in hope for the medical fraternity and patients, which will detect all four dengue virus serotypes and chikungunya virus simultaneously. Dengue and chikungunya, have almost taken epidemic proportions in the country, with 7761 cases and 129 deaths so far.

The new molecular diagnostic system has been developed by Dr Jong-Yoon Chun of Seegene Life Sciences Institute, Seoul, Korea, in collaboration with Prof Sazaly AbuBaker of the University Malaya Medical Centre in Malayasia. After successful initial evaluation on at least 300 suspected dengue and chikungunya patients, Dr Chun has now brought this technology in India.

His team is in talks with hospitals like AIIMS, Apollo, Dr Lal Path Labs and with the Government. "At the moment, we just want hospitals and labs to test the kit for its efficacy," says Dr Chun.

Scientists and doctors have already emphasised on the need for an early detection of the infections, especially by using molecular diagnostics to ensure that immediate preventive control measures can be undertaken by the authorities to curb the spread of the diseases while at the same time allow doctors to rigorously monitor confirmed dengue patients and accord proper treatment thereof in the best possible way to reduce mortality.

Where the conventional serological methods are not reliable and do not allow early detection, the Seegene's system can accurately detect and differentiate specific dengue virus serotypes (DEN1-DEN4) and chikungunya virus with just one step PCR. Prof AbuBakar was able to detect the presence of dengue virus in samples of patients as early as on day one of fever and in at least 60 per cent of the IgM negative patients that later seroconvert.

According to Dr Chun, the system is sensitive enough to detect even at a very low copy number of the virus. This allows early detection of the virus and also if there's co-infection with multiple dengue virus serotypes and/or chikungunya virus.

Back to Top

© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.